GlaxoSmithKline fined $3bn in US

<p>GlaxoSmithKline was socked with $3 billion in fines by US authorities Monday over charges it marketed drugs for unapproved uses, hold behind reserve data, and cheated a government’s Medicaid program.</p>
<p><img src="http://imageads.googleadservices.com/pagead/ads?format=468x30_aff_img&client=&channel=&output=png&cuid=3161&url=%20http%3A%2F%2Fmedicalinfo.info%2F%3Fp%3D3161" alt="ads?format=468x30_aff_img&client=&channe" /></p>...